Ad is loading...
BCYC
Price
$20.13
Change
-$0.27 (-1.32%)
Updated
Dec 2, 03:46 PM (EDT)
92 days until earnings call
RLAY
Price
$4.63
Change
-$0.07 (-1.49%)
Updated
Dec 2, 12:23 PM (EDT)
80 days until earnings call
Ad is loading...

BCYC vs RLAY

Header iconBCYC vs RLAY Comparison
Open Charts BCYC vs RLAYBanner chart's image
Bicycle Therapeutics
Price$20.13
Change-$0.27 (-1.32%)
Volume$300
CapitalizationN/A
Relay Therapeutics
Price$4.63
Change-$0.07 (-1.49%)
Volume$200
CapitalizationN/A
BCYC vs RLAY Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BCYC vs. RLAY commentary
Dec 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Sell and RLAY is a Buy.

COMPARISON
Comparison
Dec 02, 2024
Stock price -- (BCYC: $20.40 vs. RLAY: $4.70)
Brand notoriety: BCYC and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 45% vs. RLAY: 142%
Market capitalization -- BCYC: $1.41B vs. RLAY: $786.7M
BCYC [@Biotechnology] is valued at $1.41B. RLAY’s [@Biotechnology] market capitalization is $786.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.43B to $0. The average market capitalization across the [@Biotechnology] industry is $2.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and RLAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -0.68% price change this week, while RLAY (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.63%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +11.60%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 04, 2025.

RLAY is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+4.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($1.41B) has a higher market cap than RLAY($787M). BCYC YTD gains are higher at: 12.832 vs. RLAY (-57.312). BCYC has higher annual earnings (EBITDA): -160.02M vs. RLAY (-389.45M). BCYC has more cash in the bank: 891M vs. RLAY (840M). BCYC has less debt than RLAY: BCYC (11.1M) vs RLAY (49.8M). BCYC has higher revenues than RLAY: BCYC (36.9M) vs RLAY (10M).
BCYCRLAYBCYC / RLAY
Capitalization1.41B787M179%
EBITDA-160.02M-389.45M41%
Gain YTD12.832-57.312-22%
P/E RatioN/AN/A-
Revenue36.9M10M369%
Total Cash891M840M106%
Total Debt11.1M49.8M22%
TECHNICAL ANALYSIS
Technical Analysis
BCYCRLAY
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 25 days ago
87%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDIVX45.250.52
+1.16%
Fidelity Diversified International
HFYTX10.260.09
+0.88%
Hartford Schroders Intl Multi-Cp Val R5
PMGJX8.260.05
+0.61%
Principal MidCap Growth J
RSMMX10.860.04
+0.37%
Victory RS Small Cap Equity Member
TCSHX14.660.04
+0.27%
Transamerica Multi-Asset Income C

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RLAY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.25%
RLAY - BCYC
46%
Loosely correlated
-2.08%
PHIO - BCYC
41%
Loosely correlated
+3.23%
XNCR - BCYC
37%
Loosely correlated
-0.08%
SRRK - BCYC
36%
Loosely correlated
+4.59%
ORMP - BCYC
35%
Loosely correlated
N/A
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-2.08%
XNCR - RLAY
54%
Loosely correlated
-0.08%
BCYC - RLAY
45%
Loosely correlated
+0.25%
ABOS - RLAY
45%
Loosely correlated
+0.44%
TVTX - RLAY
44%
Loosely correlated
+0.59%
VCYT - RLAY
44%
Loosely correlated
+0.14%
More